| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/16/2004 | US20040254112 Use of pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 12/16/2004 | US20040254110 Methods for diagnosing and treating Alzheimer's disease |
| 12/16/2004 | US20040254108 Preparation and application of anti-tumor bifunctional fusion proteins |
| 12/16/2004 | US20040254107 Biphasic mixtures of glp-1 and insulin |
| 12/16/2004 | US20040254106 Modified factor ix |
| 12/16/2004 | US20040254103 Water-soluble shps as novel alkylating agents |
| 12/16/2004 | US20040254102 Remedies for bone diseases |
| 12/16/2004 | US20040254101 Colon specific gene and protein and cancer |
| 12/16/2004 | US20040254100 Use of thiostrepton as an anti-mycobacterial agent |
| 12/16/2004 | US20040254099 Compounds and methods for modulating beta-catenin mediated gene expression |
| 12/16/2004 | US20040254097 treating dermatological conditions related to rosacea by topically applying a composition comprising at least one peptide copper complex to an area of affected skin |
| 12/16/2004 | US20040253728 New method |
| 12/16/2004 | US20040253722 Process for the maturation of dentritic cells and a vaccine |
| 12/16/2004 | US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 12/16/2004 | US20040253708 Apo-2 ligand |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253689 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof |
| 12/16/2004 | US20040253687 Using multicompartment apparatus and affinity chromatography to isolate/purify preferential protein from cell solutions |
| 12/16/2004 | US20040253686 Novel human kunitz-type inhibitors and methods relating thereto |
| 12/16/2004 | US20040253685 eNOS mutations useful for gene therapy and therapeutic screening |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
| 12/16/2004 | US20040253681 Mitogenic oxygenase regulators |
| 12/16/2004 | US20040253678 Novel collagen production method |
| 12/16/2004 | US20040253677 mTOR kinase-associated proteins |
| 12/16/2004 | US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 12/16/2004 | US20040253672 Expression vector comprising nucleotide sequences coding signal peptide modified protein for use in identifying modulator for treatment and prevention of muscular and respiratory disorders |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253651 Detected from secreted glycoprotein (such as matrix metalloproteinases, prostate specific antigen, kallikrein 2, human chorionic gonadotrophin or carcinoembryonic antigen); glycosyltransferases; for diagnosing and targeting cell proliferative disorders; vaccines |
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/16/2004 | US20040253618 Expression vector comprising nucleotide sequences coding tumor associated membrane protein for use in diagnosis, prevention and treatment of cell proliferative disorders of urogenital systems |
| 12/16/2004 | US20040253611 Immunologically active proteins from borrelia burgdorferi |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253608 Compounds with anti-KS and anti-HIV activity |
| 12/16/2004 | US20040253605 Expression vector comprising nucleotide sequences coding aggrecanase for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/16/2004 | US20040253602 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 12/16/2004 | US20040253601 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism |
| 12/16/2004 | US20040253598 Nucleic and amino acid sequences; autoimmune/inflammatory disorders, cancer; expression vectors, host cells, antibodies, agonists, antagonists. transgenic organisms |
| 12/16/2004 | US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253587 Antagonists of interleukin-15 |
| 12/16/2004 | US20040253578 Solid support comprising immobilized dynamic action reference tools (DART)/bioconjugates for use in isolation and analysis of nucleic acids and polypeptides; drug screening |
| 12/16/2004 | US20040253326 Composition for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | US20040253325 Treating herpes zoster varicella by applying an extract of pokeweed berries as active ingredient; permeates the cells of the nerve sheath killing the virus without immune system support |
| 12/16/2004 | US20040253323 An aqueous alkali metal salt solution contains cesium and rubidium salt of chloride, sulfate, carbonate, phosphate, lactate, citrate, and acetate; antitumor agents, antiproliferative agents; inhibiting secretion of tumor proteases, increase pH to neutralize acidic hypoxic cancerous neoplasms |
| 12/16/2004 | US20040253316 Production scale method of forming microparticles |
| 12/16/2004 | US20040253294 A crosslinked, acidic, high molecular weight gelatin hydrogel obtained from alkali hydrolyzed collagen, impregnated with hepatocyte growth factor, and having an isoelectric point of 5 and a zeta potential between -15 and -20 mV; angiogenesis promoters; arterial diseases |
| 12/16/2004 | US20040253274 Use of a clostridial toxin to reduce appetite |
| 12/16/2004 | US20040253272 Process for producing inactivated virus envelopes |
| 12/16/2004 | US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 12/16/2004 | US20040253250 Compositions and methods for regulating lymphocyte activation |
| 12/16/2004 | US20040253248 Substance P-saporin (SP-SAP) conjugates and methods of use thereof |
| 12/16/2004 | US20040253247 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253241 Inducible ligand for alpha1beta1 integrin and uses |
| 12/16/2004 | US20040253239 nucleotide sequences that code angiogenic factor antagonists and vascular endothelial structure regulators, used for prevention of angoigenesis or cancer; gene therapy |
| 12/16/2004 | US20040253236 Glycoprotein VI and uses thereof |
| 12/16/2004 | US20040253235 administering interferon-beta (IFN- beta) receptor agonist and tumor associated antigen to increase an immune response against the tumor cells |
| 12/16/2004 | US20040253232 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253229 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants |
| 12/16/2004 | US20040253228 concurrently administering complexes of antigenic proteins or peptides; antimetastasis agents |
| 12/16/2004 | US20040253226 administering to the animals angiogenesis inhibitors comprising kallikreins such as prostate specific antigens (PSA), hydrolase enzymes homologs or fragments; prophylaxis of cancer, arthritis and vision defects |
| 12/16/2004 | US20040253224 genetically engineered hydrolase enzymes comprising amino acid sequence having chitinase activity, used for treating respiratory system disorders such as cystic fibrosis, chronic obstructive pulmonary disease, asthma, bronchitis or tuberculosis |
| 12/16/2004 | US20040253223 Treatment of aging disorders in humans |
| 12/16/2004 | US20040253222 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 12/16/2004 | US20040253221 Novel pla1 |
| 12/16/2004 | US20040253220 amino acid sequences of human oxidoreductase enzymes, used for activating expression of elastin; cosmetics |
| 12/16/2004 | US20040253218 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease |
| 12/16/2004 | US20040253214 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 12/16/2004 | US20040253208 Interleukin-1 muteins useful as vaccine adjuvants |
| 12/16/2004 | US20040253207 Methods and compositions for prostate epithelial cell differentiation |
| 12/16/2004 | US20040253182 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/16/2004 | US20040252660 Method for controlling connections to a mobile station |
| 12/16/2004 | CA2536472A1 Epas1 gene transfer to improve cell therapy |
| 12/16/2004 | CA2529061A1 Antimicrobial polypeptides |
| 12/16/2004 | CA2528897A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 12/16/2004 | CA2528851A1 Extracellular aspergillus polypeptides |
| 12/16/2004 | CA2528830A1 Transducible dna-binding proteins |
| 12/16/2004 | CA2528727A1 Immunomodulating compositions, uses therefor and processes for their production |
| 12/16/2004 | CA2528522A1 Antimicrobial flush solutions |
| 12/16/2004 | CA2528239A1 Mutants of the factor vii epidermal growth factor domain |
| 12/16/2004 | CA2528157A1 Cell-containing preparations |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/16/2004 | CA2528044A1 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 12/16/2004 | CA2527984A1 Vascular endothelial growth factor fusion constructs and uses thereof |
| 12/16/2004 | CA2527799A1 Methods for identifying modulators of kinesin activity |
| 12/16/2004 | CA2527711A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 12/16/2004 | CA2527665A1 Formation of novel erythropoietin conjugates using transglutaminase |
| 12/16/2004 | CA2527658A1 Methods and compositions for interferon therapy |
| 12/16/2004 | CA2526792A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 12/16/2004 | CA2526638A1 Method of mitigating the adverse effects of il-2 |
| 12/16/2004 | CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | CA2524910A1 Therapeutical composition containing dendritic cells and use thereof |
| 12/16/2004 | CA2524229A1 Canine ghrh gene, polypeptides and methods of use |
| 12/16/2004 | CA2518627A1 Method of screening antiobesity agents and animal model of obesity |
| 12/15/2004 | EP1486565A1 Combination PDGF, KGF, IGF, and IGFBP for wound healing |
| 12/15/2004 | EP1486564A1 SiRNA with increased stability in serum |
| 12/15/2004 | EP1486511A1 Refolding of polypeptides |